Exagen Inc. (XGN)
NASDAQ: XGN
· Real-Time Price · USD
6.96
-0.02 (-0.29%)
At close: May 30, 2025, 3:59 PM
6.95
-0.19%
After-hours: May 30, 2025, 04:04 PM EDT
-0.29% (1D)
| Bid | 6.5 |
| Market Cap | 152.18M |
| Revenue (ttm) | 56.72M |
| Net Income (ttm) | -15.51M |
| EPS (ttm) | -0.83 |
| PE Ratio (ttm) | -8.39 |
| Forward PE | -25.77 |
| Analyst | Strong Buy |
| Ask | 7.08 |
| Volume | 257,605 |
| Avg. Volume (20D) | 202,217 |
| Open | 6.96 |
| Previous Close | 6.98 |
| Day's Range | 6.51 - 7.12 |
| 52-Week Range | 1.71 - 7.20 |
| Beta | 1.51 |
Analyst Forecast
According to 0 analyst ratings, the average rating for XGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-9.81%
Exagen shares are trading lower after the company ...
Unlock content with
Pro Subscription
9 months ago
+12.65%
Exagen shares are trading higher after the company reported better-than-expected Q2 financial results and increased its FY24 revenue outlook above estimates.
